MYPT1 phosphatase in smooth muscle
平滑肌中的 MYPT1 磷酸酶
基本信息
- 批准号:8031260
- 负责人:
- 金额:$ 24.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-01-03 至 2012-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinity ChromatographyAgonistAmino Acid SequenceAmino AcidsAntsAssesAsthmaBlood flowCyclic NucleotidesDimensionsEnzymesFunctional disorderGastrointestinal tract structureGene SilencingGenesGoalsHealthHoloenzymesHypertensionMass Spectrum AnalysisMolecularMuscle ContractionMyosin ATPaseMyosin Regulatory Light ChainsOrganPathway interactionsPhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPhysiologyPlayPropertyProtein DephosphorylationProtein KinaseRegulationRelaxationResearchRho-associated kinaseRoleSeriesSiteSmooth MuscleSpecificityStimulusTechniquesTestingUp-RegulationUrinary systemUterusbasebody systeminhibitor/antagonistmembrane-associated placental tissue protein 1myosin phosphataserhostudy characteristics
项目摘要
DESCRIPTION (provided by applicant): The goal of proposed project is to determine the molecular identity of myosin light chain phosphatase phosphatase (MYPT1 phosphatase) and clarify the regulatory role of this poorly investigated critical component to create a molecular and cellular basis for understanding of the physiology and pathophysiology of smooth muscle contraction. Smooth muscle contraction is regulated by the Ca2+ independent pathway in addition to the well known Ca2+ dependent pathway. The key component of the Ca2+ independent pathway is myosin light chain phosphatase (MLCP), whose activity is regulated by the phosphorylation of the regulatory subunit of MLCP, called myosin targeting subunit 1(MYPT1). The research in the past has centered on the RhoA/ROCK pathway, a protein kinase phosphorylating MYPT1. However, recent studies have suggested that the Ca2+ independent regulation of MLC phosphorylation cannot solely be explained by RhoA/ROCK. We propose that MYPT1 phosphatase is the missing regulatory component that explains the unsolved research problem for understanding smooth muscle contractile regulation. Nothing is known about this important regulatory component. Our recent results have suggested that MYPT1 phosphatase is regulated during the contraction-relaxation cycle in smooth muscle (Nakamura et al., 2007). Furthermore, MYPT1 phosphatase is not inhibited by CPI17,which potently inhibits MLCP activity, suggesting that MYPT1 phosphatase is a different molecule from MLCP. Based upon these findings, we propose the following hypothesis. External stimuli alters the MYPT1 phosphatase activity, which causes the change in the MYPT1 phosphorylation level, thus regulates MLCP activity concertedly with the regulation of the RhoA/ROCK pathway. The proposed project will address this hypothesis. First we will isolate MYPT1 phosphatase from smooth muscle and determine the partial amino acid sequence of the subunits of MYPT1 using a Mass Spectrometry technique. Based upon the sequence information, we will identify the genes encoding the MYPT1 phosphatase holoenzyme and functionally express this enzyme (Aim 1). We will then study the characteristics and the regulation of MYPT1 phosphatase at the molecular level. A key question is how MYPT1 phosphatase activity is regulated. We hypothesize that the non-catalytic subunits of MYPT1 phosphatase play a key role in the regulation, and we will study the regulatory function of the non-catalytic subunits including the effect of phosphorylation using Mass Spectrometry analysis (Aim 2). In Specific Aim 3, we will test the effect of elimination of the identified MYPT1 phosphatase on MLCP activity and MLC phosphorylation in smooth muscle to confirm the importance of the identified MYPT1 phosphatase. Finally we will examine the regulation of MYPT1 phosphatase in smooth muscle by external stimuli. It is anticipated that the obtained information of MYPT1 phosphatase will provide a clue to understand the physiology and pathophysiology of organs containing smooth muscle.
PUBLIC HEALTH RELEVANCE: Smooth muscle is distributed in many organs such as vasculature, airway, digestive tract, uterus, and urinary system, and maintains or alters the dimensions of an organ against imposed loads. Hence, smooth muscle plays a critical role in maintaining blood flow in vasculature and airflow in airway and the malfunction of smooth muscle causes severe health problems such as high blood pressure and asthma. The proposed project will identify a critical, but under-investigated regulatory component, an enzyme that dephosphorylates myosin light chain phosphatase. It is anticipated that the obtained information will provide a molecular basis to understand the malfunction of smooth muscle in these organ systems.
描述(由申请方提供):拟定项目的目标是确定肌球蛋白轻链磷酸酶磷酸酶(MYPT 1磷酸酶)的分子特性,并阐明这种研究不足的关键组分的调节作用,为理解平滑肌收缩的生理学和病理生理学奠定分子和细胞基础。 平滑肌收缩除了由众所周知的Ca 2+依赖性途径调节外,还由Ca 2+非依赖性途径调节。钙非依赖性途径的关键组分是肌球蛋白轻链磷酸酶(MLCP),其活性受MLCP调节亚基(称为肌球蛋白靶向亚基1(MYPT 1))的磷酸化调节。过去的研究集中在RhoA/ROCK通路,一种磷酸化MYPT 1的蛋白激酶。然而,最近的研究表明,MLC磷酸化的Ca 2+非依赖性调节不能单独用RhoA/ROCK来解释。我们认为MYPT 1磷酸酶是缺失的调节成分,解释了理解平滑肌收缩调节的未解决的研究问题。对这一重要的监管组成部分一无所知。我们最近的结果表明,MYPT 1磷酸酶在平滑肌的收缩-舒张周期中受到调节(中村等人,2007年)。此外,MYPT 1磷酸酶不受CPI 17的抑制,CPI 17可有效抑制MLCP活性,表明MYPT 1磷酸酶是与MLCP不同的分子。基于这些发现,我们提出以下假设。外界刺激改变MYPT 1磷酸酶活性,引起MYPT 1磷酸化水平的变化,从而与RhoA/ROCK通路的调节协同调节MLCP活性。拟议的项目将解决这一假设。首先,我们将从平滑肌中分离MYPT 1磷酸酶,并使用质谱技术确定MYPT 1亚基的部分氨基酸序列。基于序列信息,我们将鉴定编码MYPT 1磷酸酶全酶的基因并功能性表达该酶(Aim 1)。我们将在分子水平上研究MYPT 1磷酸酶的特性和调控。一个关键问题是MYPT 1磷酸酶活性是如何调节的。我们假设MYPT 1磷酸酶的非催化亚基在调节中起关键作用,我们将使用质谱分析研究非催化亚基的调节功能,包括磷酸化的影响(目的2)。在特定目标3中,我们将检测消除已鉴别MYPT 1磷酸酶对平滑肌中MLCP活性和MLC磷酸化的影响,以确认已鉴别MYPT 1磷酸酶的重要性。最后,我们将研究MYPT 1磷酸酶在平滑肌的调节由外部刺激。预期所获得的MYPT 1磷酸酶的信息将为了解含有平滑肌的器官的生理和病理生理提供线索。
公共卫生相关性:平滑肌分布在许多器官中,例如脉管系统、气道、消化道、子宫和泌尿系统,并且维持或改变器官的尺寸以抵抗施加的负荷。因此,平滑肌在维持脉管系统中的血流和气道中的气流中起关键作用,并且平滑肌的功能障碍导致严重的健康问题,例如高血压和哮喘。拟议的项目将确定一个关键的,但研究不足的监管组成部分,一种酶,去磷酸化肌球蛋白轻链磷酸酶。预计所获得的信息将提供分子基础,以了解这些器官系统中的平滑肌功能障碍。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mitsuo Ikebe其他文献
Mitsuo Ikebe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mitsuo Ikebe', 18)}}的其他基金
Regulation of Myosin Phosphorylation in Smooth Muscle
平滑肌肌球蛋白磷酸化的调节
- 批准号:
6719089 - 财政年份:2003
- 资助金额:
$ 24.68万 - 项目类别:
Regulation of Myosin Phosphorylation in Smooth Muscle
平滑肌肌球蛋白磷酸化的调节
- 批准号:
6873033 - 财政年份:2003
- 资助金额:
$ 24.68万 - 项目类别:
Regulation of Myosin Phosphorylation in Smooth Muscle
平滑肌肌球蛋白磷酸化的调节
- 批准号:
8488458 - 财政年份:2003
- 资助金额:
$ 24.68万 - 项目类别:
Regulation of Myosin Phosphorylation in Smooth Muscle
平滑肌肌球蛋白磷酸化的调节
- 批准号:
8828337 - 财政年份:2003
- 资助金额:
$ 24.68万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 24.68万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 24.68万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 24.68万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 24.68万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 24.68万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 24.68万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 24.68万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 24.68万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 24.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 24.68万 - 项目类别:
Collaborative Research and Development Grants